Views

All Case Studies Views Resources Whitepapers Podcasts On-Demand Webinars
A Year in Review: Looking Back at 2024
In this end of year review, we look back on 2024 to summarize how the year shaped up in our health economics and outcomes research (HEOR) space. Find out more.
View Jan 20, 2025
IRA Webinar Series – Part 2: IRA Impact on Innovation in Drug Development
Precision medicine is the commitment to deliver the right therapy to the right patient at the right time. This is a challenging goal, especially in oncology, given the wide diversity of diseases and patients. To address the challenges, drug developers are increasingly analyzing real world data (RWD) to generate real-world evidence (RWE) to complement what can be learned from traditional randomized, controlled clinical trials (RCTs).
View Dec 5, 2024
Using Real World Data to Guide Precision Oncology Drug Development
Precision medicine is the commitment to deliver the right therapy to the right patient at the right time. This is a challenging goal, especially in oncology, given the wide diversity of diseases and patients. To address the challenges, drug developers are increasingly analyzing real world data (RWD) to generate real-world evidence (RWE) to complement what can be learned from traditional randomized, controlled clinical trials (RCTs).
View Nov 25, 2024